Professor Robert Clancy developed the vaccine Broncostat at the University of Newcastle in 1985. Broncostat reduces attacks of acute bronchitis to a degree of 90%.[1] Broncostat was commercialised in 1989 by Rhone-Poulenc Rorer Australia Pty. Ltd.[2]